Zurn Elkay reported ten percent organic sales growth and raised full-year EBITDA guidance to $503 million.
| Quarter | Q2 FY26 |
|---|---|
| Call date | 2026-07-29 |
| Length | 49 minutes |
| EPS | $0.50 |
| EPS consensus | $0.47 |
| Revenue | $491.0M |
What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.
Other quarters: Q1 FY26 · Q4 FY25 · Q3 FY25
Read the full Q2 FY26 earnings call transcript
All ZWS earnings · Back to ZWS overview
Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.